Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

PWD/Ph-Encoded Genetic Variants Modulate the Cellular Wnt/β-Catenin Response to Suppress ApcMin-Triggered Intestinal Tumor Formation

AL. Farrall, M. Lienhard, C. Grimm, H. Kuhl, SHM. Sluka, M. Caparros, J. Forejt, B. Timmermann, R. Herwig, BG. Herrmann, M. Morkel

. 2021 ; 81 (1) : 38-49. [pub] 20201105

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019504

Genetic predisposition affects the penetrance of tumor-initiating mutations, such as APC mutations that stabilize β-catenin and cause intestinal tumors in mice and humans. However, the mechanisms involved in genetically predisposed penetrance are not well understood. Here, we analyzed tumor multiplicity and gene expression in tumor-prone ApcMin/+ mice on highly variant C57BL/6J (B6) and PWD/Ph (PWD) genetic backgrounds. (B6 × PWD) F1 APCMin offspring mice were largely free of intestinal adenoma, and several chromosome substitution (consomic) strains carrying single PWD chromosomes on the B6 genetic background displayed reduced adenoma numbers. Multiple dosage-dependent modifier loci on PWD chromosome 5 each contributed to tumor suppression. Activation of β-catenin-driven and stem cell-specific gene expression in the presence of ApcMin or following APC loss remained moderate in intestines carrying PWD chromosome 5, suggesting that PWD variants restrict adenoma initiation by controlling stem cell homeostasis. Gene expression of modifier candidates and DNA methylation on chromosome 5 were predominantly cis controlled and largely reflected parental patterns, providing a genetic basis for inheritance of tumor susceptibility. Human SNP variants of several modifier candidates were depleted in colorectal cancer genomes, suggesting that similar mechanisms may also affect the penetrance of cancer driver mutations in humans. Overall, our analysis highlights the strong impact that multiple genetic variants acting in networks can exert on tumor development. SIGNIFICANCE: These findings in mice show that, in addition to accidental mutations, cancer risk is determined by networks of individual gene variants.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019504
003      
CZ-PrNML
005      
20210830101103.0
007      
ta
008      
210728s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1158/0008-5472.CAN-20-1480 $2 doi
035    __
$a (PubMed)33154092
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Farrall, Alexandra L $u Max Planck Institute for Molecular Genetics, Berlin, Germany $u College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia
245    10
$a PWD/Ph-Encoded Genetic Variants Modulate the Cellular Wnt/β-Catenin Response to Suppress ApcMin-Triggered Intestinal Tumor Formation / $c AL. Farrall, M. Lienhard, C. Grimm, H. Kuhl, SHM. Sluka, M. Caparros, J. Forejt, B. Timmermann, R. Herwig, BG. Herrmann, M. Morkel
520    9_
$a Genetic predisposition affects the penetrance of tumor-initiating mutations, such as APC mutations that stabilize β-catenin and cause intestinal tumors in mice and humans. However, the mechanisms involved in genetically predisposed penetrance are not well understood. Here, we analyzed tumor multiplicity and gene expression in tumor-prone ApcMin/+ mice on highly variant C57BL/6J (B6) and PWD/Ph (PWD) genetic backgrounds. (B6 × PWD) F1 APCMin offspring mice were largely free of intestinal adenoma, and several chromosome substitution (consomic) strains carrying single PWD chromosomes on the B6 genetic background displayed reduced adenoma numbers. Multiple dosage-dependent modifier loci on PWD chromosome 5 each contributed to tumor suppression. Activation of β-catenin-driven and stem cell-specific gene expression in the presence of ApcMin or following APC loss remained moderate in intestines carrying PWD chromosome 5, suggesting that PWD variants restrict adenoma initiation by controlling stem cell homeostasis. Gene expression of modifier candidates and DNA methylation on chromosome 5 were predominantly cis controlled and largely reflected parental patterns, providing a genetic basis for inheritance of tumor susceptibility. Human SNP variants of several modifier candidates were depleted in colorectal cancer genomes, suggesting that similar mechanisms may also affect the penetrance of cancer driver mutations in humans. Overall, our analysis highlights the strong impact that multiple genetic variants acting in networks can exert on tumor development. SIGNIFICANCE: These findings in mice show that, in addition to accidental mutations, cancer risk is determined by networks of individual gene variants.
650    _2
$a zvířata $7 D000818
650    _2
$a nádorová transformace buněk $x genetika $x metabolismus $x patologie $7 D002471
650    _2
$a kolorektální nádory $x genetika $x patologie $x prevence a kontrola $7 D015179
650    12
$a geny APC $7 D017491
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a střeva $x patologie $7 D007422
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    12
$a mutace $7 D009154
650    _2
$a proteiny Wnt $x genetika $x metabolismus $7 D051153
650    _2
$a beta-katenin $x genetika $x metabolismus $7 D051176
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lienhard, Matthias $u Max Planck Institute for Molecular Genetics, Berlin, Germany
700    1_
$a Grimm, Christina $u Max Planck Institute for Molecular Genetics, Berlin, Germany $u Department of Translational Epigenetics and Tumor Genetics, University Hospital Cologne, Cologne, Germany
700    1_
$a Kuhl, Heiner $u Max Planck Institute for Molecular Genetics, Berlin, Germany $u Leibniz-Institute of Freshwater Ecology and Inland Fisheries, Department of Ecophysiology and Aquaculture, Berlin, Germany
700    1_
$a Sluka, Susanna H M $u Max Planck Institute for Molecular Genetics, Berlin, Germany
700    1_
$a Caparros, Marta $u Max Planck Institute for Molecular Genetics, Berlin, Germany
700    1_
$a Forejt, Jiri $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vestec, Prague, Czech Republic
700    1_
$a Timmermann, Bernd $u Max Planck Institute for Molecular Genetics, Berlin, Germany
700    1_
$a Herwig, Ralf $u Max Planck Institute for Molecular Genetics, Berlin, Germany
700    1_
$a Herrmann, Bernhard G $u Max Planck Institute for Molecular Genetics, Berlin, Germany. Markus.Morkel@charite.de herrmann@molgen.mpg.de $u Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute for Medical Genetics, Berlin, Germany
700    1_
$a Morkel, Markus $u Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany. Markus.Morkel@charite.de herrmann@molgen.mpg.de
773    0_
$w MED00009437 $t Cancer research $x 1538-7445 $g Roč. 81, č. 1 (2021), s. 38-49
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33154092 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101103 $b ABA008
999    __
$a ok $b bmc $g 1690350 $s 1139950
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 81 $c 1 $d 38-49 $e 20201105 $i 1538-7445 $m Cancer research $n Cancer Res $x MED00009437
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...